MICROSATELLITE INSTABILITY OF COLORECTAL CANCERS IN PATIENTS FROM THE REPUBLIC OF MACEDONIA
Stefanovska A-M1,*, Jasar D2,*, Zografski G2, Josifovski T3, Panovski M3, Efremov GD1, Dimovski AJ1
*Corresponding Author: Dr. Aleksandar J. Dimovski, Macedonian Academy of Sciences and Arts, Research Center for Genetic Engineering and Biotechnology, Aven Krste Misirkov 2, POB 428, 1000 Skopje, Republic of Macedonia; Tel: +3892-120253; Fax: +3892-115434; E-mail: aleks@manu.edu.mk
page: 11

DISCUSSION

In this paper we describe the analysis of the MSI status in a cohort of colorectal cancer patients from Macedonia. The study was conducted with two different methods, nonradioactive PCR-PAGE and fluorescent multiplex PCR/capillary electrophoresis assay. Similar results were obtained with both methods, making the fluorescent multi­plex PCR the method of choice for a routine MSI analysis due to its simplicity, speed and lesser manipulation requirements. From the five microsatellite markers used in this study, the BAT26 exhibited 100% sensitivity and 100% specificity in the detection of MSI-H phenotype in tumors. The sensitivity and specificity for D17S250, D18S61, D18S58 and DCC markers were 81.8 and 100%, 72.7 and 98.9%, 63.6 and 98.9%, and 45.5 and 98.9%, respectively. These data support the suggestion of Yamamoto et al. [20] that BAT26 can be used as a single marker for the detection of MSI status in colorectal tumors.

The frequency of MSI in our group of patients was 10.3% which is within the reported range in several exten­sive studies [11,21]. None of the tumors with the MSI-H phenotype had nodal involvement, and 10/11 of these were right sided (caecum, colon ascendens and transversum). These tumors were also associated with lower Dukes’ stage at diagnosis and primarily mucinous histotype. These data are in agreement with the general opinion about the histopathological characteristics and MSI status of colo­rectal tumors [21]. However, MSI status was not associated with age in our group of patients, contrary to several studies published recently [13,21]. Bearing in mind that HNPCC is generally associated with a younger age at diagnosis, in comparison with cases with the sporadic form of the disease, one of the possible explanations of this discrepancy is that there is a lower frequency of HNPCC carriers in our group of patients. Since this was a retrospective study, we did not have sufficient information on the family history of each patient, or enough material to conduct mutational analyses of MMR genes to clarify this issue. A prospective study is underway which should resolve this question in the near future.

Instability at only one locus was detected in three patients. In a recent study it was concluded that this type of instability can be detected in most, if not all, colorectal carcinomas, if a sufficient number of markers is used [17]. Other authors have presented evidence that the MSH6 gene inactivation is associated with MSI-L phenotype [22]. Since no detailed family history and no material for MSH6 gene analysis was available, it is difficult to discriminate between these two possibilities, and this issue will also be addressed in the ongoing prospective study.

 

Fig. 1. Detection of MSI phenotype at three loci by PCR-PAGE (left) and fluorescent PCR/capillary electrophoresis (right).

 

 

Table 1. MSI status for each of the seven markers in the 14 MSI positive tumors

 

 

 

Table 2. The frequency of MSI at the seven markers in MSI-H and MSI-L tumors

 

 

 

Table 3. Association of MSI status and some clinical and histopathological features in 107 patients with colorectal cancer

 

 




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006